Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 2Completed 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Hemorrhage 6Leiomyoma 3Hematologic Neoplasms 3Urinary Bladder Neoplasms 2Seizures 2Postoperative Hemorrhage 2Ovarian Neoplasms 2Neoplasms 2Menorrhagia 2Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Thrombocytopenia 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Seroma 1Sepsis 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Prostatic Neoplasms 1Postoperative Complications 1Pneumonia 1Patient Satisfaction 1Pain 1Osteosarcoma 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79Bevacizumab 75pembrolizumab 74Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Tranexamic Acid × Clear all
NCT01980355 2023-08-07

TXA

Corewell Health West

Phase NA Completed
76 enrolled 9 charts
Tumor-Agnostic

Neoplasms

NCT01651182 2015-09-18

Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection

Sunnybrook Health Sciences Centre

Phase 3 Completed
24 enrolled

Hemorrhage, Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡